Showing results (241-250 of 361) with videos related to

Sort By:
Pageof 37
Gynecologie, Obstetrique & Fertilite|March 19, 2013
[Are vaginal pap smear necessary after total hysterectomy for CIN3?]F Nicolas, L Vandenbroucke, M C Voltzenlogel, et al.
Critical Care Medicine|May 1, 1990
Fulminant hepatic failure in poisoning due to ingestion of T 61, a veterinary euthanasia drugF Nicolas, P Rodineau, J M Rouzioux, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 1, 1985
Heterogeneity of thymic epithelial cell (TEC) keratins--immunohistochemical and biochemical evidence for a subset of highly differentiated TEC in the mouseJ F Nicolas, W Savino, A Reano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cellsC Desvignes, N Etchart, J Kehren, et al.
Intensive Care Medicine|March 29, 2003
A universal method for determining intensive care unit bed requirementsJ M Nguyen, P Six, R Parisot, et al.
Allergy|May 7, 2009
Allergic hypersensitivity to topical and systemic corticosteroids: a reviewM Baeck, L Marot, J-F Nicolas, et al.
Medical & Biological Engineering & Computing|February 25, 2016
Neurofeedback training with a motor imagery-based BCI: neurocognitive improvements and EEG changes in the elderlyJavier Gomez-Pilar, Rebeca Corralejo, Luis F Nicolas-Alonso, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 9, 2015
Assessment of neurofeedback training by means of motor imagery based-BCI for cognitive rehabilitationJ Gomez-Pilar, R Corralejo, L F Nicolas-Alonso, et al.
Contact Dermatitis|November 1, 1996
Suboptimal non-inflammatory concentrations of haptens may elicit a contact sensitivity reaction when used as a mixM Krasteva, J L Garrigue, F Horrand, et al.
Dermatologica|January 1, 1989
Treatment of cutaneous T cell lymphoma with intermediate doses of interferon alpha 2aJ F Nicolas, J C Balblanc, A Frappaz, et al.
Pageof 37